NBY

NovaBay Pharmaceuticals Stock Price

0.7209
0.0029 (0.4%)
Upgrade to Real-Time
Regular Market
0.7209
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
NovaBay Pharmaceuticals Inc New NBY AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0029 0.4% 0.7209 12:08:28
Close Price Low Price High Price Open Price Previous Close
0.72 0.74 0.721 0.718
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
359 147,603 $ 0.7263275 $ 107,208 3,161,656 0.20 - 2.18
Last Trade Time Type Quantity Stock Price Currency
12:07:25 28 $ 0.7215 USD

NovaBay Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 30.09M 41.74M 31.22M $ 6.60M $ -6.40M -0.53 -4.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
515.08k $ - 0.00% - -

more financials information »

NovaBay Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NBY Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.78810.800.690.7388675451,112-0.0672-8.53%
1 Month0.900.93720.670.7860116923,773-0.1791-19.9%
3 Months1.132.180.671.204,911,665-0.4091-36.2%
6 Months0.80012.180.53821.124,626,583-0.0792-9.9%
1 Year0.64972.180.201.102,915,8290.071210.96%
3 Years4.5554.800.201.291,300,034-3.83-84.17%
5 Years8.509.320.201.40814,927-7.78-91.52%

NovaBay Pharmaceuticals Description

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops, manufactures, and markets anti-infective products for a multitude of uses. It is predominantly focused on commercializing prescription Avenova for the domestic eye care market in the United States. Avenova is the only eye care product formulated with proprietary, stable and pure form of hypochlorous acid (marketed as Neutrox). The company develops additional products containing Neutrox, including its NeutroPhase Skin and Wound Cleanser for wound care and CelleRx for the dermatology market. It has partnerships for NeutroPhase in the United States, as well as in other markets.


Your Recent History
AMEX
NBY
NovaBay Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.